Banxia Baizhu Tianma decoction for hyperlipidemia Protocol for a systematic review and meta-analysis

被引:12
作者
Cai, Hairong [1 ,2 ]
Guo, Yongning [1 ]
Zhao, Zicong [1 ]
Chen, Yanhong [1 ]
Zhao, Shuai [1 ]
Chen, Bojun [1 ,2 ]
机构
[1] Guangzhou Univ Chinese Med, Sch Clin Med 2, Guangzhou, Guangdong, Peoples R China
[2] Guangzhou Univ Chinese Med, Dept Emergency, Affiliated Hosp 2, 55 Neihuanxi Rd, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Banxia Baizhu Tianmao decoction; hyperlipidemia; protocol; systematic review; CARDIOVASCULAR-DISEASE; STATIN THERAPY; DYSLIPIDEMIA; PREVENTION; CORONARY; RECOMMENDATIONS; ASSOCIATION; CHOLESTEROL; PREVALENCE; MANAGEMENT;
D O I
10.1097/MD.0000000000013067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hyperlipidemia is one of the most common metabolic diseases worldwide, as well as a leading risk factor for cardio-erebrovascular diseases. Banxia Baizhu Tianma decoction (BBTD) is widely used for the treatment of hyperlipidemia in China, however, systematic review and meta-analysis regarding its efficacy and safety is lacking. The aim of this protocol of systematic review is to evaluate the effectiveness and safety of BBTD in the treatment of hyperlipidemia. Methods: We will include the randomized controlled trials estimating the effectiveness and safety of BBTD in the treatment of hyperlipidemia. Data sources will include 5 English databases (PubMed, EMBASE, Cochrane Library, Web of Science, CINAHL) and 4 Chinese databases (CMB, CNKI, VIP, Wanfang database). The literature to be collected will be from the time when databases were established to September 2018. Efficacy will be accepted as the primary outcome, while blood lipid levels and adverse reactions as the secondary outcome. Study selection, data collection, risk of bias assessment, and evaluation of the quality of the evidence will be conducted by 2 x 2 different reviewers. Statistical syntheses will be conducted by using RevMan software V.5.3. Results: This study will provide a high-quality evidence for BBTD on the treatment of hyperlipidemia from efficacy, serum lipid levels, and adverse reactions. Conclusion: The result will provide a basis for judging whether BBTD is an effective intervention for the treatment of hyperlipidemia. PROSPERO registration number: PROSPERO CRD 42018081359.
引用
收藏
页数:4
相关论文
共 18 条
[1]   The safety of statins in clinical practice [J].
Armitage, Jane .
LANCET, 2007, 370 (9601) :1781-1790
[2]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[3]  
Duan L., 2014, J TRADIT CHIN MED SC, V1, P140, DOI DOI 10.1016/J.JTCMS.2014.11.011
[4]   Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update [J].
Harris, P. E. ;
Cooper, K. L. ;
Relton, C. ;
Thomas, K. J. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (10) :924-939
[5]   National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1-Full Report [J].
Jacobson, Terry A. ;
Ito, Matthew K. ;
Maki, Kevin C. ;
Orringer, Carl E. ;
Bays, Harold E. ;
Jones, Peter H. ;
McKenney, James M. ;
Grundy, Scott M. ;
Gill, Edward A. ;
Wild, Robert A. ;
Wilson, Don P. ;
Brown, W. Virgil .
JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (02) :129-169
[6]   AACE Task Force for the Management of Dyslipidemia and Prevention of Atherosclerosis Writing Committee [J].
Jellinger, Paul S. ;
Smith, Donald A. ;
Mehta, Adi E. ;
Ganda, Om ;
Handelsman, Yehuda ;
Rodbard, Helena W. ;
Shepherd, Mark D. ;
Seibel, John A. .
ENDOCRINE PRACTICE, 2012, 18 (02) :270-293
[7]   Dyslipidemia, Coronary Artery Calcium, and Incident Atherosclerotic Cardiovascular Disease Implications for Statin Therapy From the Multi-Ethnic Study of Atherosclerosis [J].
Martin, Seth S. ;
Blaha, Michael J. ;
Blankstein, Ron ;
Agatston, Arthur ;
Rivera, Juan J. ;
Virani, Salim S. ;
Ouyang, Pamela ;
Jones, Steven R. ;
Blumenthal, Roger S. ;
Budoff, Matthew J. ;
Nasir, Khurram .
CIRCULATION, 2014, 129 (01) :77-+
[8]   Canadian Cardiovascular Society position statement - Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease [J].
McPherson, Ruth ;
Frohlich, Jiri ;
Fodor, George ;
Genest, Jacques .
CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 (11) :913-927
[9]   The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials [J].
Mihaylova, B. ;
Emberson, J. ;
Blackwell, L. ;
Keech, A. ;
Simes, J. ;
Barnes, E. H. ;
Voysey, M. ;
Gray, A. ;
Collins, R. ;
Baigent, C. ;
de Lemos, J. ;
Braunwald, E. ;
Blazing, M. ;
Murphy, S. ;
Downs, J. R. ;
Gotto, A. ;
Clearfield, M. ;
Holdaas, H. ;
Gordon, D. ;
Davis, B. ;
Koren, M. ;
Dahlof, B. ;
Poulter, N. ;
Sever, P. ;
Knopp, R. H. ;
Fellstrom, B. ;
Holdaas, H. ;
Jardine, A. ;
Schmieder, R. ;
Zannad, F. ;
Goldbourt, U. ;
Kaplinsky, E. ;
Colhoun, H. M. ;
Betteridge, D. J. ;
Durrington, P. N. ;
Hitman, G. A. ;
Fuller, J. ;
Neil, A. ;
Wanner, C. ;
Krane, V. ;
Sacks, F. ;
Moye, L. ;
Pfeffer, M. ;
Hawkins, C. M. ;
Braunwald, E. ;
Kjekshus, J. ;
Wedel, H. ;
Wikstrand, J. ;
Barter, P. ;
Keech, A. .
LANCET, 2012, 380 (9841) :581-590
[10]   The prevalence, awareness, treatment and control of dyslipidemia among adults in China [J].
Pan, Ling ;
Yang, Zhenhua ;
Wu, Yue ;
Yin, Rui-Xing ;
Liao, Yunhua ;
Wang, Jinwei ;
Gao, Bixia ;
Zhang, Luxia .
ATHEROSCLEROSIS, 2016, 248 :2-9